Article ID Journal Published Year Pages File Type
3204120 The Journal of Allergy and Clinical Immunology: In Practice 2014 10 Pages PDF
Abstract
Omalizumab is statistically significantly associated with symptom relief, decreased rescue medication use, and improvement of quality of life in patients with inadequately controlled allergic rhinosinusitis.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , ,